{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.2","upperLimit":"30.7","value":"22.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"title":"Males that received leuprolide"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.2","upperLimit":"32.5","value":"21.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"}],"units":"Participants"}],"title":"Males that did not receive leuprolide"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.1","upperLimit":"50.5","value":"14.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"}],"units":"Participants"}],"title":"Females who all received leuprolide"}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"}],"units":"Participants"}],"description":"B cell percentage is defined as the percentage of lymphocytes that are B cells.","dispersionType":"Full Range","groups":[{"description":"Patients receiving first allogeneic bone marrow transplant on this study.","id":"OG000","title":"Transplant Recipient"}],"paramType":"MEDIAN","populationDescription":"Only first BMT patients (SG1-3) with \\>1 year of follow-up without relapse were evaluable. Of evaluable patients, 5 males and 9 females received and 7 males did not receive Lupron. Reasons for patients being inevaluable were missing data (2) or insufficient follow-up due to death without relapse (3), relapse (11), or withdrawal (1) before 1 year.","reportingStatus":"POSTED","timeFrame":"after first Bone Marrow Transplant, approximately 12 months post-transplant","title":"Percentage of B Cells at One Year Post-transplant in Participants Who Did/Did Not Receive Leuprolide Following Bone Marrow Transplant (BMT)","type":"PRIMARY","unitOfMeasure":"percentage of cells"}